An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y‐27632, a Rho kinase inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y‐27632, a Rho kinase inhibitor

Published:2019-02-18 Issue:2 Volume:37 Page:113-124
ISSN:0263-6484
Container-title:Cell Biochemistry and Function
language:en
Short-container-title:Cell Biochem Funct

Author:

Ibrahim Diah Gemala¹²^ORCID,Ko Ji‐Ae¹^ORCID,Iwata Wakana¹,Okumichi Hideaki¹,Kiuchi Yoshiaki¹

Affiliation:

1. Department of Ophthalmology and Visual ScienceHiroshima University Hiroshima Japan

2. Department of OphthalmologyHasanuddin University Makassar Indonesia

Funder

Indonesia Endowment Fund for Education (LPDP), Ministry of Finance, Republic of Indonesia

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,General Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbf.3382

Reference53 articles.

1. Current concepts in the pathophysiology of glaucoma

2. The Pathophysiology and Treatment of Glaucoma

3. The definition and classification of glaucoma in prevalence surveys

4. The number of people with glaucoma worldwide in 2010 and 2020

5. Discovery of novel inhibitors for the treatment of glaucoma

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrence following ptosis repair surgery: a multivariate analysis of risk factors;Orbit;2024-09-02

2. Tenon’s patch grafting: An inexpensive technique for managing corneal perforation and descemetocele - Our experience of 12 months post-operative follow-up;Indian Journal of Clinical and Experimental Ophthalmology;2024-07-15

3. Effect of ripasudil after trabeculectomy with mitomycin C: a multicentre, randomised, prospective clinical study;BMJ Open Ophthalmology;2024-07

4. The Application of Rho Kinase Inhibitors in the Management of Glaucoma;International Journal of Molecular Sciences;2024-05-21

5. Rho Kinase (ROCK) Inhibitors for the Treatment of Glaucoma;Current Drug Targets;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3